Table 2 Proportion of HPV genotypes in HPV positive patients

High-risk^a

42 (72.4) [58.9–83.0]

12 (75.0) [47.4–91.7]

50 (72.5) [60.2–82.2]

 16

6 (10.3) [4.3–21.8]

1 (6.3) [0.3–32.3]

7 (10.1) [4.5–20.4]

 18

10 (17.2) [9.0–29.9]

9 (56.3) [30.6–79.3]

19 (27.5) [17.8–39.8]

 31

2 (3.4) [0.6–13.0]

0

2 (2.9) [0.5–11.0]

 33

1 (1.7) [0.1–10.5]

0

1 (1.4) [0.1–8.9]

 35

1 (1.7) [0.1–10.5]

0

1 (1.4) [0.1–8.9]

 39

4 (6.9) [2.2–17.6]

1 (6.3) [0.3–32.3]

5 (7.2) [2.7–16.8]

 45

1 (1.7) [0.1–10.5]

0

1 (1.4) [0.1–8.9]

 51

5 (8.6) [3.2–19.7]

0

5 (7.2) [2.7–16.8]

 52

10 (17.2) [9.0–29.9]

0

10 (14.5) [7.5–25.5]

 56

2 (3.4) [0.6–13.0]

1 (6.3) [0.3–32.3]

3 (4.3) [1.1–13.0]

 58

5 (8.6) [3.2–19.7]

0

5 (7.2) [2.7–16.8]

 59

4 (6.9) [2.2–17.6]

1 (6.3) [0.3–32.3]

5 (7.2) [2.7–16.8]

 68

7 (12.1) [5.4–23.9]

0

7 (10.1) [4.5–20.4]

Low-risk^a

36 (62.1) [48.4–74.2]

6 (37.5) [16.3–64.1]

41 (59.4) [46.9–70.9]

 30

1 (1.7) [0.1–10.5]

0

1 (1.4) [0.1–8.9]

 53

3 (5.2) [1.3–15.3]

1 (6.3) [0.3–32.3]

4 (5.8) [1.9–14.9]

 66

1 (1.7) [0.1–10.5]

1 (6.3) [0.3–32.3]

2 (2.9) [0.5–11.0]

 6

7 (12.1) [5.4–23.9]

0

7 (10.1) [4.5–20.4]

 11

7 (12.1) [5.4–23.9]

2 (12.5) [2.2–39.6]

8 (11.6) [5.5–22.1]

 40

1 (1.7) [0.1–10.5]

0

1 (1.4) [0.1–8.9]

 42

2 (3.4) [0.6–13.0]

1 (6.3) [0.3–32.3]

3 (4.3) [1.1–13.0]

 43

5 (8.6) [3.2–19.7]

0

5 (7.2) [2.7–16.8]

 44

1 (1.7) [0.1–10.5]

0

1 (1.4) [0.1–8.9]

 74

2 (3.4) [0.6–13.0]

0

2 (2.9) [0.5–11.0]

 76

1 (1.7) [0.1–10.5]

0

1 (1.4) [0.1–8.9]

 81

11 (19.0) [10.3–31.8]

1 (6.3) [0.3–32.3]

12 (17.4) [9.7–28.8]

 90

2 (3.4) [0.6–13.0]

0

2 (2.9) [0.5–11.0]

 114

1 (1.7) [0.1–10.5]

0

1 (1.4) [0.1–8.9]

Total strains

103

19

121